First Nine Months of 2012 Sees Syncardia’s Best Year For Implants and Revenue



SynCardia Exceeds Best Year to Date for Implants and Revenue in the First Nine Months of 2012 (via PR Newswire)

TUCSON, Ariz., Oct. 11, 2012 /PRNewswire/ — SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that revenue and implants for the first nine months of 2012 have exceeded the company…